ATE372342T1 - Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva - Google Patents
Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressivaInfo
- Publication number
- ATE372342T1 ATE372342T1 AT03714897T AT03714897T ATE372342T1 AT E372342 T1 ATE372342 T1 AT E372342T1 AT 03714897 T AT03714897 T AT 03714897T AT 03714897 T AT03714897 T AT 03714897T AT E372342 T1 ATE372342 T1 AT E372342T1
- Authority
- AT
- Austria
- Prior art keywords
- aminoisoxazoline
- antidepressants
- derivatives
- substituted
- substituted aminoisoxazoline
- Prior art date
Links
- XPZOKPQZEPSMFC-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazol-3-amine Chemical class NC1=NOCC1 XPZOKPQZEPSMFC-UHFFFAOYSA-N 0.000 title 1
- 239000000935 antidepressant agent Substances 0.000 title 1
- 229940005513 antidepressants Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02076239 | 2002-04-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE372342T1 true ATE372342T1 (de) | 2007-09-15 |
Family
ID=28459528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03714897T ATE372342T1 (de) | 2002-04-02 | 2003-03-27 | Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7265103B2 (de) |
| EP (1) | EP1492796B1 (de) |
| JP (1) | JP4580653B2 (de) |
| KR (1) | KR20040093061A (de) |
| CN (1) | CN100349897C (de) |
| AR (1) | AR039207A1 (de) |
| AT (1) | ATE372342T1 (de) |
| BR (1) | BR0308309A (de) |
| CA (1) | CA2480113C (de) |
| DE (1) | DE60316134T2 (de) |
| DK (1) | DK1492796T3 (de) |
| EA (1) | EA008189B1 (de) |
| ES (1) | ES2292949T3 (de) |
| HK (1) | HK1080072A1 (de) |
| HR (1) | HRP20040871A2 (de) |
| IL (2) | IL164341A0 (de) |
| MX (1) | MXPA04008626A (de) |
| NO (1) | NO20044645L (de) |
| NZ (1) | NZ536109A (de) |
| PL (1) | PL211708B1 (de) |
| PT (1) | PT1492796E (de) |
| TW (1) | TWI286138B (de) |
| WO (1) | WO2003082878A1 (de) |
| ZA (1) | ZA200407904B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR040967A1 (es) * | 2002-08-12 | 2005-04-27 | Janssen Pharmaceutica Nv | Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos |
| CN1303085C (zh) * | 2002-08-21 | 2007-03-07 | 詹森药业有限公司 | C6－和c9－取代的异噁唑啉衍生物和它们作为抗抑郁药的用途 |
| ES2331144T3 (es) | 2004-11-26 | 2009-12-22 | Janssen Pharmaceutica Nv | Derivados de isoxazolina-indol con actividad antipsicotica y ansiolitica mejorada. |
| WO2009003867A1 (en) * | 2007-07-03 | 2009-01-08 | F. Hoffmann-La Roche Ag | 4-imidazolines and their use as antidepressants |
| US8288390B2 (en) | 2009-03-10 | 2012-10-16 | Takeda Pharmaceutical Company Limited | Benzofuran derivatives |
| US20130062732A1 (en) | 2011-09-08 | 2013-03-14 | International Business Machines Corporation | Interconnect structures with functional components and methods for fabrication |
| CN105801510A (zh) * | 2016-04-08 | 2016-07-27 | 李勇 | 一种治疗抑郁症的药物组合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0361577B1 (de) | 1988-09-19 | 1993-05-05 | Akzo N.V. | Tetrahydronaphthalin und Indan-Derivate |
| JP3161737B2 (ja) * | 1996-01-05 | 2001-04-25 | ヘキスト・マリオン・ルセル・インコーポレイテツド | ＣＮＳ活性を有する４，５―ジヒドロナフト［１，２―ｃ］イソキサゾールおよびその誘導体 |
| US6187774B1 (en) | 1996-03-04 | 2001-02-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and pharmaceutical applications thereof |
| SI1368358T1 (sl) * | 2001-02-21 | 2007-02-28 | Janssen Pharmaceutica Nv | Izoksazolinski derivati kot antidepresivi |
| AR040967A1 (es) * | 2002-08-12 | 2005-04-27 | Janssen Pharmaceutica Nv | Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos |
| CN1303085C (zh) * | 2002-08-21 | 2007-03-07 | 詹森药业有限公司 | C6－和c9－取代的异噁唑啉衍生物和它们作为抗抑郁药的用途 |
-
2003
- 2003-03-27 AT AT03714897T patent/ATE372342T1/de not_active IP Right Cessation
- 2003-03-27 PL PL371630A patent/PL211708B1/pl unknown
- 2003-03-27 HK HK05112213.1A patent/HK1080072A1/zh unknown
- 2003-03-27 JP JP2003580343A patent/JP4580653B2/ja not_active Expired - Fee Related
- 2003-03-27 DK DK03714897T patent/DK1492796T3/da active
- 2003-03-27 MX MXPA04008626A patent/MXPA04008626A/es active IP Right Grant
- 2003-03-27 BR BR0308309-8A patent/BR0308309A/pt not_active IP Right Cessation
- 2003-03-27 KR KR10-2004-7012757A patent/KR20040093061A/ko not_active Ceased
- 2003-03-27 CA CA2480113A patent/CA2480113C/en not_active Expired - Fee Related
- 2003-03-27 EA EA200401297A patent/EA008189B1/ru not_active IP Right Cessation
- 2003-03-27 US US10/510,220 patent/US7265103B2/en not_active Expired - Lifetime
- 2003-03-27 ES ES03714897T patent/ES2292949T3/es not_active Expired - Lifetime
- 2003-03-27 PT PT03714897T patent/PT1492796E/pt unknown
- 2003-03-27 WO PCT/EP2003/003245 patent/WO2003082878A1/en not_active Ceased
- 2003-03-27 IL IL16434103A patent/IL164341A0/xx unknown
- 2003-03-27 CN CNB038074192A patent/CN100349897C/zh not_active Expired - Fee Related
- 2003-03-27 DE DE60316134T patent/DE60316134T2/de not_active Expired - Lifetime
- 2003-03-27 NZ NZ536109A patent/NZ536109A/en unknown
- 2003-03-27 EP EP03714897A patent/EP1492796B1/de not_active Expired - Lifetime
- 2003-03-27 HR HR20040871A patent/HRP20040871A2/hr not_active Application Discontinuation
- 2003-04-01 AR ARP030101126A patent/AR039207A1/es unknown
- 2003-04-01 TW TW092107328A patent/TWI286138B/zh not_active IP Right Cessation
-
2004
- 2004-09-28 IL IL164341A patent/IL164341A/en not_active IP Right Cessation
- 2004-09-30 ZA ZA200407904A patent/ZA200407904B/xx unknown
- 2004-10-27 NO NO20044645A patent/NO20044645L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PT1492796E (pt) | 2007-11-16 |
| TW200406414A (en) | 2004-05-01 |
| TWI286138B (en) | 2007-09-01 |
| EP1492796A1 (de) | 2005-01-05 |
| ZA200407904B (en) | 2005-10-20 |
| DE60316134D1 (de) | 2007-10-18 |
| NZ536109A (en) | 2006-06-30 |
| CA2480113C (en) | 2012-04-24 |
| HK1080072A1 (zh) | 2006-04-21 |
| KR20040093061A (ko) | 2004-11-04 |
| CA2480113A1 (en) | 2003-10-09 |
| DK1492796T3 (da) | 2007-12-03 |
| PL371630A1 (en) | 2005-06-27 |
| US7265103B2 (en) | 2007-09-04 |
| DE60316134T2 (de) | 2008-05-29 |
| AR039207A1 (es) | 2005-02-09 |
| CN1642960A (zh) | 2005-07-20 |
| WO2003082878A1 (en) | 2003-10-09 |
| NO20044645L (no) | 2004-10-27 |
| EP1492796B1 (de) | 2007-09-05 |
| HRP20040871A2 (en) | 2005-04-30 |
| ES2292949T3 (es) | 2008-03-16 |
| AU2003219111A1 (en) | 2003-10-13 |
| IL164341A (en) | 2009-06-15 |
| EA008189B1 (ru) | 2007-04-27 |
| PL211708B1 (pl) | 2012-06-29 |
| JP2005522469A (ja) | 2005-07-28 |
| CN100349897C (zh) | 2007-11-21 |
| BR0308309A (pt) | 2004-12-28 |
| MXPA04008626A (es) | 2004-12-06 |
| US20050222125A1 (en) | 2005-10-06 |
| EA200401297A1 (ru) | 2005-02-24 |
| JP4580653B2 (ja) | 2010-11-17 |
| IL164341A0 (en) | 2005-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60314600D1 (de) | O-cyclopropyl-carboxanilide und ihre verwendung als fungizide | |
| DE60309874D1 (de) | Malonsäuerenitril-verbindungen und ihre verwendung als pestizide | |
| DE60317093D1 (de) | Chinolin-; isochinolin- und chinazolinoxyalkylamide und ihre verwendung als fungizide | |
| DE60316012D1 (de) | Purinderivate und ihre verwendung als liganden des cannabinoid rezeptors | |
| ATE424202T1 (de) | Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung | |
| DE60036803D1 (de) | Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel | |
| DE50207849D1 (de) | Substituierte 2-oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre verwendung | |
| DE60208661D1 (de) | Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren | |
| ATE395339T1 (de) | Biphenylderivate und deren verwendung als fungizide | |
| DE602004028934D1 (de) | Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung | |
| DE60321958D1 (de) | Indazolderivate und ihre verwendung als crf antagonisten | |
| ATE440093T1 (de) | 1-alkinyl-2-aryloxyalkylamide und ihre verwendung als fungizide | |
| DE602004010426D1 (de) | Mikrobizide zusammensetzungen und ihre verwendung | |
| ATE432701T1 (de) | Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatoren | |
| ATE329906T1 (de) | Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren | |
| DE502005007106D1 (de) | Substituierte phenylaminothiazole und ihre verwendung | |
| DE60318733D1 (de) | Substituierte benzoxazinones und ihre verwendung | |
| DE50313157D1 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
| ATE362469T1 (de) | 2,7-disubstituierteindole und ihre verwendung als 5-ht6 modulatoren | |
| DE602004021384D1 (de) | Indol-5 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren | |
| ATE353083T1 (de) | Naphthyridin-derivate und ihre verwendung als fungizide | |
| ATE427748T1 (de) | Pyridin-derivate und ihre verwendung als urotensin ii antagonisten | |
| DE60230162D1 (de) | Polymerisate und ihre verwendung | |
| DE60321372D1 (de) | 3-phenylpyridoindolderivate, ihre herstellung und verwendung | |
| DE60324586D1 (de) | Substituierte pyridyloxyalkylamide und ihre verwendung als fungizide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1492796 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |